Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.360
+0.060 (4.62%)
At close: Mar 20, 2026, 4:00 PM EDT
1.350
-0.010 (-0.74%)
After-hours: Mar 20, 2026, 6:51 PM EDT
Daré Bioscience Employees
As of December 31, 2024, Daré Bioscience had 23 total employees, including 21 full-time and 2 part-time employees. The number of employees decreased by 3 or -11.54% compared to the previous year.
Employees
23
Change (1Y)
-3
Growth (1Y)
-11.54%
Revenue / Employee
n/a
Profits / Employee
-$759,302
Market Cap
19.43M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 23 | -3 | -11.54% | 21 | 2 |
| Dec 31, 2023 | 26 | -4 | -13.33% | 23 | 3 |
| Dec 31, 2022 | 30 | 2 | 7.14% | 25 | 5 |
| Dec 31, 2021 | 28 | 5 | 21.74% | 20 | 8 |
| Dec 31, 2020 | 23 | 5 | 27.78% | 16 | 7 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Citius Pharmaceuticals | 23 |
| IN8bio | 17 |
| FibroBiologics | 15 |
| VYNE Therapeutics | 10 |
| Lexaria Bioscience | 7 |
| Traws Pharma | 7 |
| Allarity Therapeutics | 7 |
| Intensity Therapeutics | 7 |
DARE News
- 5 days ago - Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-PTB1, its Novel Intravaginal Ring for Prevention of Preterm Birth - GlobeNewsWire
- 9 days ago - Daré Bioscience Participates in Virtual Investor “What This Means” Segment - GlobeNewsWire
- 26 days ago - Daré Bioscience Announces FDA Clearance of IND for Phase 2 Clinical Study of DARE-HPV, a Potential Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer - GlobeNewsWire
- 3 months ago - DARE to PLAY™ Sildenafil Cream Now Available for Pre-Order by Prescription: First Evidence-Based Topical Arousal Cream for Women Begins Commercial Rollout in Select States via 503B Outsourcing Facility - GlobeNewsWire
- 4 months ago - Daré Bioscience Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025 - GlobeNewsWire
- 6 months ago - Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research - GlobeNewsWire
- 7 months ago - Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire